| Names | |
|---|---|
|  IUPAC name  Methyl 19α-methyl-2-oxoformosanan-16-carboxylate  | |
|  Systematic IUPAC name  Methyl (1′S,3R,4′aS,5′aS,10′aR)-1′-methyl-2-oxo-1,2,4′a,5′,5′a,7′,8′,10′a-octahydro-1′H,10′H-spiro[indole-3,6′-pyrano[3,4-f]indolizine]-4′-carboxylate  | |
| Identifiers | |
3D model (JSmol)  | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.007.370 | 
| EC Number | 
  | 
| KEGG | |
 PubChem CID  | |
| UNII | |
 CompTox Dashboard (EPA)  | |
  | |
  | |
| Properties | |
| C21H24N2O4 | |
| Molar mass | 368.1736 g/mol | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).  | |
Mitraphylline, an oxindole derivative, is an active alkaloid in the leaves of the tree Mitragyna speciosa , commonly known as kratom. [1] As a non-narcotic constituent, it also occurs to a significant amount in the bark of Uncaria tomentosa (Cat's Claw) along with a number of isomeric alkaloids. [2]
Current research is focusing on antiproliferative and cytotoxic effects and its in vivo efficacy to induce apoptosis in human breast cancer, sarcoma, as well as lymphoblastic leukemia cell lines. [3] [4] [5] [6] [7] [8]